Association between BMI and colorectal cancer risk
the ONA take:
High pre-diagnosis body mass index (BMI) was associated with increased mortality among patients with colorectal cancer, a new study published in the journal Cancer Epidemiology, Biomarkers & Prevention has shown.
For the study, researchers sought to evaluate the association between BMI and colorectal cancer survival. Researchers analyzed data from 5,615 men and women diagnosed with invasive colorectal cancer who were followed for an average of 5.9 years.
Results showed that high pre-diagnosis BMI was associated with a higher risk of all-cause mortality. The risk of death did not significantly vary by sex, location of cancer, or BRAF mutation status.
According to the National Cancer Institute, previous research has demonstrated that a higher BMI is strongly associated with an increased risk for colorectal cancer among men. A strong association between BMI and waist circumference with colon cancer has been observed in men, with a weaker association observed in women.
High pre-diagnosis body mass index (BMI) was associated with increased mortality among patients with colorectal cancer.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|